Polidocanol endovenous microfoam (Varithena) 1% for treatment of varicose veins
HAYES, Inc.
Record ID 32016000963
English
Authors' recommendations:
Description of Technology: The polidocanol endovenous microfoam (PEM) (also known as polidocanol injectable foam) 1% evaluated in this report, Varithena (Provensis Ltd.), is a prescribed proprietary canister that generates a sterile, uniform, stable, low-nitrogen polidocanol 1% microfoam sclerosant intended for ultrasound-guided intravenous injection for treating venous incompetence and varicosities.
Patient Population: Proprietary PEM 1% (Varithena) is intended for treating incompetent great saphenous veins, accessory saphenous veins, and visible varicosities above and below the knee. However, optimal patient selection criteria have not been established.
Details
Project Status:
Completed
Year Published:
2016
URL for published report:
The report may be purchased from: http://www.hayesinc.com/hayes/crd/?crd=19166
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Humans
- Polyethylene Glycols
- Varicose Veins
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
2014 Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.